Summary

Global Catheter Market Size

Catheter Market is expected to reach US$ 51.65 billion in 2033 from US$ 25.32 billion in 2024, with a CAGR of 8.25% from 2025 to 2033. The market is being driven by the growing prevalence of chronic illnesses, including as diabetes, cardiovascular disease, and urinary tract problems, which have led to a greater requirement for catheterization procedures.


Catheter Industry Overview

A catheter is a tiny tube that is put into a patient's body for medical and diagnostic purposes. Medical-grade materials like plastic, latex, silicone rubbers, nylon, and polyvinyl chloride (PVC) are used in its production. Cardiovascular, neurovascular, urinary, intravenous, and specialized catheters are a few of the widely accessible varieties. In addition to monitoring and controlling the outflow of body fluids, including urine, during surgery and the recovery period after surgery, they are utilized in acute care facilities to provide medications and gasses to patients. Catheters are so widely used to treat a wide range of cardiovascular, urological, and neurovascular conditions.

The rising incidence of urological problems worldwide is one of the main reasons propelling the market's expansion. Additionally, the growing number of elderly people, who are more prone to these conditions, and the growing demand for minimally invasive operations (MI) are driving the market's expansion. In hospitals, clinics, and other healthcare facilities, these catheters are also frequently used for electrophysiology procedures, which involve inserting wire electrodes into catheters to assess electrical activity in the blood arteries that supply the heart. Other technical developments are also contributing to increase, such as the use of robot-assisted surgical procedures. Accordingly, the production of antimicrobial catheters with silver ion coatings is promoting market expansion by reducing the frequency of thrombosis and catheter-associated illnesses. It is projected that the market will develop due to additional variables, such as the general public's increasing ability to pay for medical operations and the notable advancements in the healthcare system.


Growth Drivers for the Catheter Market

Growth in chronic diseases

The market for catheters is expected to increase significantly due to the rising incidence of chronic illnesses such diabetes, renal problems, and cardiovascular diseases. In order to diagnose, treat, and manage these disorders, catheter-based therapies are frequently necessary. For example, people with diabetes may need dialysis catheters for kidney-related disorders, while patients with cardiovascular problems may need catheterization for angioplasty. Cardiovascular disorders, which impact the heart and blood arteries and can result in heart attacks, strokes, or heart failure, claim the lives of 18 million people annually. Every year, about 9 million people pass away from cancer, 4 million from long-term respiratory conditions like COPD or asthma, and 2 million from diabetes. Furthermore, in March 2021, the Brain Aneurysm Foundation reported that brain aneurysms cause over 500,000 deaths worldwide each year, with half of those deaths occurring in those under the age of 50. In the United States, the yearly rupture rate is approximately 30,000, or 8–10 cases per 100,000. The need for catheter-based medical operations is growing as chronic diseases proliferate throughout the world, especially as the population ages. This tendency propels the market for a variety of catheter types, including dialysis, cardiovascular, and urine catheters, and it helps the industry expand.


Technological Advancement

The market for catheters is expanding due in large part to technological developments. Catheters are now safer, more comfortable, and more effective because to innovations like the creation of sophisticated materials, coatings, and biocompatible surfaces. These enhancements enhance patient outcomes and lower the chance of problems like infections. Furthermore, the use of catheters in diagnosis and treatment has increased because to the incorporation of smart technology like wireless monitoring and pressure sensors. Demand in the market is being driven by the growing use of minimally invasive catheter designs, which provide easier insertion and faster recovery in a variety of medical operations.

In Feb 2023, Eleflex Incorporated announced the 510(k) clearance of its Triumph Catheter from the U.S. FDA. This cutting-edge gadget has precise wire advancement and vivid visualization. Additionally, the company announced that its GuideLiner Coast Catheter was used clinically for the first time at the UW Medicine Heart Institute in Seattle, Washington.


Growing Investment in Healthcare

An important factor propelling the catheter market's expansion is the rise in healthcare expenditures. More financing is enhancing healthcare infrastructure, increasing access to cutting-edge medical technologies, and promoting the uptake of novel medical equipment, such as catheters, in both established and emerging nations. Modern healthcare facilities, diagnostic tools, and minimally invasive procedures—all of which depend on catheter-based interventions—are receiving top priority investments from governments, commercial institutions, and healthcare organizations. This increase in healthcare spending is especially noticeable in Asia-Pacific and Latin America, where rising healthcare knowledge and access are driving up demand for different kinds of catheters and propelling market expansion.


Challenges in the Catheter Market

High Costs

The market for catheters is severely hampered by high prices, especially for sophisticated catheter technology utilized in specialist treatments. Expensive research and development, materials, and manufacturing all add to the final cost. Accessibility may be hampered by this, particularly in low- and middle-income nations where healthcare spending is limited. Consequently, cost-effectiveness and affordability emerge as major obstacles to the broad use of certain catheter technologies.


Regulatory Hurdles

In the catheter industry, regulatory obstacles are a major problem because different regions have different strict criteria for product approval and safety regulations. Time-to-market may be delayed by the complicated standards that manufacturers must follow, which include stringent testing, clinical trials, and documentation. Particularly for small and medium-sized businesses, these drawn-out approval procedures raise expenses and impede innovation. Additionally, shifting laws and disparate standards across markets may add to the complexity, restricting access to and growth in international markets.


Transcatheter Aortic Valve Replacement (TAVR) has become the leading procedure in the global catheter market.

Transcatheter Aortic Valve Replacement (TAVR) has captured the biggest percentage of the global catheter market size due to its progressive method of treating aortic valve diseases. TAVR offers a minimally invasive alternative to standard open-coronary heart surgical procedures, making it appropriate for a broader patient demographic. Its ability to increase life expectancy and enhance quality of life, specifically amongst aged and high-risk patients, has pushed its speedy adoption. Moreover, improvements in technology and medical expertise have increased safety and efficacy. TAVR's less invasive nature reduces restoration instances and hospital stays, making it a cost-effective and patient-friendly preference, solidifying its dominant position within the catheter market.


The global catheter market is witnessing a rise in the use of biological tissue.

Biological tissue is gaining prominence in the worldwide catheter market size due to its first-rate biocompatibility and ability to lower complications. As sufferers demand more secure and powerful medical techniques, the mixing of organic materials in catheters addresses this need. Bio-engineered tissues, along with the ones derived from animal or human resources, closely mimic the body's properties, lowering the hazard of adverse reactions or infections. These revolutionary catheters hold promise for packages like cardiovascular and urinary interventions, where minimizing irritation and improving recovery are paramount. The developing emphasis on patient effects, coupled with advancing biotechnology, guarantees that organic tissue continues to thrive within the catheter market.


Hospitals continue to hold a dominant share in the global catheter industry.

Hospitals, in most cases, dominate the global catheter market size, and this is attributed to their capacity to harness economies of scale as a way to secure stable pricing agreements with catheter producers. This cost-effective method allows hospitals to keep a sizable catheter supply while upholding top-tier patient care requirements. As a result, their strategic procurement strategies and infrastructure assist them as the key catalyst for the significant adoption of catheters, in addition to solidifying their outstanding popularity in the worldwide catheter market.


The transaortic approach is projected to grow at the fastest rate.

The transaortic technique is poised for the quickest growth in the global catheter market size due to its flexible application and minimally invasive nature. It gives an instantaneous path to the coronary heart and is increasingly popular in transcatheter aortic valve replacement (TAVR) and other cardiac procedures. This method minimizes trauma and reduces healing times, making it attractive to both patients and physicians. With ongoing improvements and expanding indicators for the transaortic approach, it's expected to witness speedy adoption, driving its extended growth in the catheter market.


Aortic stenosis is expected to dominate the global catheter industry

Aortic stenosis will lead in the worldwide catheter market size because of its high prevalence and the vital need for an effective remedy. This condition, characterized by a narrowed aortic valve, often necessitates catheter-based interventions like transcatheter aortic valve replacement (TAVR). As the elderly population grows, so does the prevalence of aortic stenosis, fueling demand for these strategies. Advancements in catheter technology and increasing patient recognition solidify its prominence, making aortic stenosis the driving force in the worldwide catheter market size.


Catheter Market Overview by Regions

The market for catheters is expanding worldwide, with North America leading the way because of its sophisticated healthcare system and strong demand for minimally invasive procedures. The Asia-Pacific area is expanding quickly as a result of increased healthcare access and an older population, while Europe comes in second with significant healthcare investments. Demand is also rising in the Middle East and Latin America.


United States Catheter Market

Increased demand for minimally invasive procedures, the prevalence of chronic diseases, and improved healthcare infrastructure have made the US one of the world's largest markets for catheters. High healthcare costs, technological breakthroughs in catheter designs, and the aging population are important contributing causes. The market gains from strict laws governing medical devices and an emphasis on enhancing patient outcomes. The dialysis, cardiovascular, and urinary catheter markets are the main categories. The market is expanding due to ongoing innovation and rising demand for homecare products.

According to Linear Health Sciences, the U.S. FDA approved the Orchid SRV safety released valves in October 2023. The catheter was designed to lessen the risk of IV catheter rupture and repair in hospitals, and it was approved for use in all IV access procedures.


Germany Catheter Market

Germany's sophisticated healthcare system, first-rate medical infrastructure, and strong emphasis on innovation have made it one of the continent's leading catheter markets. Growing numbers of senior people are good for the market since they increase the need for catheters to treat age-related illnesses such kidney, urinary, and cardiovascular problems. Technological developments in catheter designs, like minimally invasive procedures and biocompatible materials, also support expansion. Catheters are widely used in hospitals, clinics, and homecare settings thanks to Germany's strong healthcare spending and strict regulatory environment, which both contribute to the country's strong product standards and market expansion.


India Catheter Market

India's catheter industry is expanding rapidly, driven mostly by the region's aging population and rising rates of chronic illnesses. The need for medical interventions increases with the aging population, which fuels the growing use of catheters. Furthermore, new catheter designs have been created as a result of medical technological breakthroughs, improving both the catheters' effectiveness and patient comfort. Catheters are also required for both diagnostic and therapeutic purposes due to the rising prevalence of cardiovascular diseases, urinary disorders, and neurovascular ailments.

Additionally, the need for catheters has increased due to growing knowledge of minimally invasive procedures, which are essential in lowering the invasiveness of medical interventions. The market for catheters is further supported by the growing emphasis on at-home healthcare and the growing popularity of outpatient operations, which help patients and healthcare cost containment. Additionally, by encouraging R&D efforts, strategic partnerships between manufacturers and healthcare providers help to expand the market. In conclusion, the market for catheters in India is driven by a combination of factors such as growing illness prevalence, technological advancements, demographic changes, and a growing inclination towards minimally invasive procedures, all of which indicate a vibrant and dynamic healthcare sector.


UAE Catheter Market

A growing older population, rising chronic illness prevalence, and greater healthcare investments are all driving growth in the UAE catheter market. Demand for a variety of catheter types, including cardiovascular and urinary catheters, is driven by the nation's sophisticated medical infrastructure, which is bolstered by government programs and the growth of private healthcare. Additionally, technological innovations like minimally invasive procedures are becoming more popular. Furthermore, the UAE's advantageous position as a Middle Eastern medical center encourages the local and regional markets to adopt cutting-edge catheter technologies.


Type – Market breakup from 3 viewpoints:
1. TAVR
2. TMVR
3. TPVR


Material – Market breakup from 2 viewpoints:
1. Mechanical tissue
2. Biological tissue


End-User – Market breakup from 3 viewpoints:
1. Hospitals
2. Ambulatory surgical centers
3. Others


Product – Market breakup from 4 viewpoints:
1. Transfemoral approach
2. Transapical approach
3. Transaortic approach
4. Others


Application – Market breakup from 3 viewpoints:
1. Aortic Stenosis
2. Aortic Regurgitation
3. Others


Region – Market breakup from 25 Country viewpoints:
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa


All companies have been covered from 3 viewpoints:
• Overview
• Recent Development
• Revenue


Company Analysis:
1. Abbott Laboratories
2. Becton Dickinson and Company
3. Boston Scientific Corporation
4. Teleflex Incorporated
5. Medtronic Plc.
6. Johnson & Johnson
7. Edwards Lifesciences Corporation
8. Stryker Corporation


Key Questions Answered in Report:

1. How big is the catheter industry?
The global catheter market size was valued at US$ 51.65 billion in 2024 and is expected to reach US$ 25.32 billion in 2033.

2. What is the catheter growth rate?
The global catheter market is expected to expand at a compound annual growth rate (CAGR) of 8.25% from 2025 to 2033.

3. Who are the key players in catheter industry?
Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Teleflex Incorporated, Medtronic Plc., Johnson & Johnson, Edwards Lifesciences Corporation, and Stryker Corporation are the major competitors in the global catheters market.

4. What are the factors driving the catheter industry?
Key growth drivers of the catheter market include increasing chronic diseases, aging populations, advancements in catheter technology, rising demand for minimally invasive procedures, and growing healthcare investments globally.

5. Which Region held the largest market share in the catheter industry?
North America is expected to hold the largest market share in the industry.

6. What segments are covered in the catheter market report?
Type, Material, End-User, Products, Application and Countries segment are covered in this report.

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Catheters Market

6. Market Share

6.1 By Product Type

6.1.1 Cardiovascular Catheters
6.1.2 Neurovascular Catheters
6.1.3 Urinary Catheters
6.1.4 Intravascular Catheters

6.2 By End Users

6.3 By Countries


7. Product Type

7.1 Cardiovascular Catheters

7.1.1 Cardiovascular Therapeutic Catheters
7.1.2 Cardiovascular Diagnostic Catheters

7.2 Neurovascular Catheters

7.2.1 Microcatheters
7.2.2 Balloon Catheters
7.2.3 Access Catheters
7.2.4 Embolization Catheters
7.2.5 Others

7.3 Urinary Catheters

7.3.1 Intermittent Catheters
7.3.2 Foley/Indwelling Catheters
7.3.3 External Catheters

7.4 Intravascular Catheters

7.4.1 Short PIVC
7.4.2 Integrated/Closed PIVC

7.5 Specialty Catheters


8. End Users

8.1 Hospitals
8.2 Ambulatory Surgical Centers
8.3 Diagnostic Imaging Centers
8.4 Others


9. Countries

9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherland
9.2.8 Turkey

9.3 Asia Pacific

9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Thailand
9.3.6 Malaysia
9.3.7 Indonesia
9.3.8 Australia
9.3.9 New Zealand

9.4 Latin America

9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina

9.5 Middle East & Africa

9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 South Africa


10. Porter’s Five Forces Analysis

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis

11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat


12. Key Players Analysis

12.1 Abbott Laboratories

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Revenue Analysis

12.2 Becton Dickinson And Company

12.2.1 Overview
12.2.2 Recent Development
12.2.3 Revenue Analysis

12.3 Boston Scientific Corporation

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Revenue Analysis

12.4 Teleflex Incorporated

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Revenue Analysis

12.5 Medtronic Plc.

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Revenue Analysis

12.6 Johnson & Johnson

12.6.1 Overview
12.6.2 Recent Development
12.6.3 Revenue Analysis

12.7 Edwards Lifesciences Corporation

12.7.1 Overview
12.7.2 Recent Development
12.7.3 Revenue Analysis

12.8 Stryker Corporation

12.8.1 Overview
12.8.2 Recent Development
12.8.3 Revenue Analysis